1. Zhao, Kaidong, Gao, Ming, Lin, Min. 2022. KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma. In Disease markers, 2022, 3373851. doi:10.1155/2022/3373851. https://pubmed.ncbi.nlm.nih.gov/36193495/
2. Sidiropoulos, Konstantinos G, Ding, Qiang, Pampalakis, Georgios, Sotiropoulou, Georgia, Yousef, George M. 2016. KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes. In Molecular oncology, 10, 993-1007. doi:10.1016/j.molonc.2016.03.008. https://pubmed.ncbi.nlm.nih.gov/27093921/
3. Pampalakis, Georgios, Zingkou, Eleni, Sidiropoulos, Konstantinos Gus, Yousef, George M, Sotiropoulou, Georgia. 2019. Biochemical pathways mediated by KLK6 protease in breast cancer. In Molecular oncology, 13, 2329-2343. doi:10.1002/1878-0261.12493. https://pubmed.ncbi.nlm.nih.gov/30980596/
4. Pampalakis, Georgios, Zingkou, Eleni, Zoumpourlis, Vassilis, Sotiropoulou, Georgia. 2020. Ectopic expression of KLK6 in MDA-MB-435 melanoma cells reduces tumorigenicity in vivo. In Pathology, research and practice, 217, 153276. doi:10.1016/j.prp.2020.153276. https://pubmed.ncbi.nlm.nih.gov/33249398/
5. Yoon, Hyesook, Triplet, Erin M, Simon, Whitney L, Miller, Aubry K, Scarisbrick, Isobel A. 2021. Blocking Kallikrein 6 promotes developmental myelination. In Glia, 70, 430-450. doi:10.1002/glia.24100. https://pubmed.ncbi.nlm.nih.gov/34626143/
智鼠故事 
